In The News
- Home
- In The News
Clinical Announcement
We are pleased to announce that RevitalLife is participating in an Institutional Review Board (IRB) study evaluating the efficacy of stem cell and exosome therapies for orthopedic indications, with particular emphasis on shoulder and knee conditions.
Exosome Research Updates
- Exosome Isolation Market Set to Reach USD 1.39 Billion by 2036 as - openPR.com
- Synthetic Exosome Engineering Market Next Big Thing | Major Giants Lonza, Merck KGaA, ReNeuron - openPR.com
- Rest-Of-Europe Exosome Research Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
- Asia-Pacific Exosome Research Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
- Eye Tracking Solutions Market Research Reveals Strong 25.5% CAGR Outlook Through 2030 - openPR.com
- Eye Infections Market Intelligence Report Covers Trends, Segments And Regional Growth - openPR.com
- MEDI-K Introduces Exosome Firming Up Ampoule, Targeting Modern Skin Firmness and Hydration Needs - openPR.com
- Exosome Technologies Market Report Examines Industry Trends, Growth Drivers And Future Outlook - openPR.com
- Excimer Laser Market Report Examines Leading Companies And Growth Opportunities - openPR.com
- Enzyme-Linked Immunosorbent Assay Testing Market Report 2026 - openPR.com
Stem Cell Research Updates
- Targeted Differentiation of Regional Ventral Neuroprogenitors and Related Neuronal Subtypes from Human Pluripotent Stem Cells
- Genetic Engineering of Human Embryonic Stem Cells for Precise Cell Fate Tracing during Human Lineage Development
- Brain corticogenesis promotes SARS-CoV-2 neuro-glial tropism through lipid-dependent viral replication
- Unproven stem cell-based interventions marketed as treatments in Panama: An urgent call for enforcement actions
- The imprinted Peg3 gene is a potent regulator of the DNA methylome in trophoblast cells
- High and intermittent hydrostatic pressure promotes maturation of engineered cardiac tissues derived from human pluripotent stem cells
- Allogeneic iPSC-derived γδT cells demonstrate antitumor efficacy against patient-derived tissues
- Targeting mitotic kinesin KIF20A: A differentiation-based therapeutic strategy for glioblastoma stem/progenitor cells
- Single cell CRISPR screen identifies antagonism between Nsd1-H3K36me2 and Ezh2-H3K27me3 orchestrates pluripotency transition
- CCL5 exposure promotes acute and transient megakaryopoiesis and hematopoietic progenitor expansion